AKAP4 expression increases significantly with the advancement of the tumour stage and is independent of age, gender, smoking history or cancer subtype, suggesting that AKAP4 is a highly accurate biomarker for the detection of early-stage lung cancer and prediction of lung cancer progression (66). Here, AKAP4 is linked to lung carcinoma.